{
  "id": 17966726,
  "title": "Camlin Fine Sciences Q2 FY27 slides: revenue up 9%, margins collapse",
  "url": "https://urgent.news/2026/11/03/camlin-fine-sciences-q2-fy27-slides-revenue-up-9-margins-collapse",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-03T13:14:51.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/camlin-fine-sciences-q2-fy27-slides-revenue-up-9-margins-collapse-93CH-4995103"
  },
  "original_language": "en",
  "account": "Camlin Fine Sciences saw a 9% rise in revenue for Q2 FY27, reaching Rs 4,915 million, but profitability took a sharp dive. EBITDA margins fell to 0.45% from 7.91% a year prior. The company disclosed a rights issue of up to Rs 2,500 million to combat liquidity issues. Revenue growth in Q2 FY27 was 9.15% YoY, while H1 FY27 saw a 17.9% increase to Rs 10,113 million. However, operational EBITDA dropped to Rs 22 million in Q2 FY27 from Rs 356 million in the previous year, with margins plummeting to 0.45% from 7.91%. Net losses widened to Rs 281 million in Q2 FY27 and Rs 599 million on a half-year basis, compared to previous losses of Rs 19 million and Rs 50 million respectively. Gross margins contracted to 39.8% in Q2 FY27 from 46.5% in the prior-quarter, driven by higher raw material prices. The specialty ingredients segment showed resilience, with revenue growing 26% YoY to Rs 1,108 million. The Blends segment also grew 25% to Rs 2,970 million. In stark contrast, the Aroma segment saw a 41% revenue drop to Rs 472 million and a negative EBITDA margin of 23.1%. Performance Chemicals & Others posted a revenue increase of 18% YoY but generated a negative EBITDA margin of 10.6%. The company's liquidity position was strained, with total equity declining to Rs 9,313.6 million as of September 2026.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}